What you should know:
– Today, Butterfly Network announced it received 510(k) clearance from the FDA for a groundbreaking AI-enabled tool named AI-enabled Auto B-line Counter that will help physicians assess adults’ lungs and accelerate providers’ abilities to make informed treatment decisions. Butterfly used data inputs from hundreds across the country to train its AI algorithms. This allows for potential for a wide range of ages, genders, body mass indexes, ethnicities, and races.
– With this new tool, providers in just six seconds will be able to quickly detect markers of congestive heart failure, chronic obstructive pulmonary disease, pneumonia and COVID-19. Instead of waiting for blood tests or x-rays to be done, patients will be able quickly scan the Butterfly device in ERs and clinics. They can also be treated much faster.
– The company anticipates that the AI-enabled Auto B-line Counter will launch early summer in the United States.